Effects of testosterone administration on growth hormone pulse dynamics in human immunodeficiency virus-infected women.

What Was Tested

The paper reports a study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over), published as a randomized controlled trial.

The effects of testosterone administration on the GH axis in androgen-deficient HIV-infected women are unknown.

In this study, the researchers determined the effects of transdermal testosterone administration on GH secretory dynamics and pulse characteristics in this population.

Who Took Part

The age groups tagged for this paper are adults and middle-aged adults, women only.

How the Study Was Run

In design terms this was a randomized and placebo-controlled study.

The participants were allocated by chance, so the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) group and the comparison group should start out alike.

The comparison arm used a placebo, so changes seen with Exogenous HGH, sermorelin & older GHRPs (why they're passed over) could be set against what happens without it.

What Was Measured

The effects of testosterone administration on the GH axis in androgen-deficient HIV-infected women are unknown.

In this study, the researchers determined the effects of transdermal testosterone administration on GH secretory dynamics and pulse characteristics in this population.

Topics PubMed links to this paper include Administration, Cutaneous, Estradiol, HIV Infections, Human Growth Hormone, Insulin-Like Growth Factor I and Testosterone.

What This Means in Plain Language

The paper is a randomized and placebo-controlled study of Exogenous HGH, sermorelin & older GHRPs (why they're passed over).

The publication is from 2004 (The Journal of clinical endocrinology and metabolism), a journal based in United States.

More context: the Exogenous HGH, sermorelin & older GHRPs (why they're passed over) compound page, all human trials.